![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 15/113 | |
C12N 15/11 | |||
C12Q 1/68 | |||
A61K 31/712 | |||
A61K 31/7125 | |||
A61K 31/713 | |||
C12Q 1/6883 | |||
A61P 43/00 |
(11) | Number of the document | 3390636 |
(13) | Kind of document | T |
(96) | European patent application number | 16876616.0 |
Date of filing the European patent application | 2016-12-14 | |
(97) | Date of publication of the European application | 2018-10-24 |
(45) | Date of publication and mention of the grant of the patent | 2021-05-19 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/066708 |
Date | 2016-12-14 |
(87) | Number | WO 2017/106377 |
Date | 2017-06-22 |
(30) | Number | Date | Country code |
201562267251 P | 2015-12-14 | US |
(72) |
AZNAREZ, Isabel, US
NASH, Huw M., US
KRAINER, Adrian, US
|
(73) |
COLD SPRING HARBOR LABORATORY,
One Bungtown Road Nicholas Building P.O. Box 100, Cold Spring Harbor, NY 11724,
US
Stoke Therapeutics, Inc., 3 Preston Court, Bedford, Massachusetts 01730, US |
(54) | ANTISENSE OLIGOMERS FOR TREATMENT OF DRAVET SYNDROME |
ANTISENSE OLIGOMERS FOR TREATMENT OF DRAVET SYNDROME |